<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1079</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>8568253</PubmedId>
            <Abstract>Listeria monocytogenes is a pathogenic intracellular bacterium that secretes proteins into the cytosol of host cells. A major secreted protein, p60, is processed by the host cell into the nonamer peptides p60 217-225 and p60 449-457, which are presented to CTL by H-2Kd MHC class I molecules. Herein, we use two membrane permeable peptide aldehyde protease inhibitors, LLnL and Z-LLF, to inhibit cytosolic proteolysis in L. monocytogenes-infected cells. These inhibitors, which have been shown to inhibit proteasomes, completely abrogate cytosolic p60 degradation. The effect of LLnL and Z-LLF on p60 epitope generation was determined by acid-eluting, HPLC-purifying, and quantifying p60 217-225 and p60 449-457 from infected cells. We show a direct linkage between p60 degradation and epitope generation. However, the two inhibitors have quantitatively different effects on the generation of the two epitopes. Our findings implicate proteasomes in the earliest stages of Ag degradation and suggest that different CTL epitopes can be generated by distinct proteolytic processes.</Abstract>
            <ArticleYear>1996</ArticleYear>
            <ArticlePages>1497-503</ArticlePages>
            <ArticleTitle>CTL epitope generation is tightly linked to cellular proteolysis of a Listeria monocytogenes antigen.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Sijts</LastName>
                    <ForeName>A J</ForeName>
                </Author>
                <Author>
                    <LastName>Villanueva</LastName>
                    <ForeName>M S</ForeName>
                </Author>
                <Author>
                    <LastName>Pamer</LastName>
                    <ForeName>E G</ForeName>
                </Author>
            </Authors>
            <Affiliations>Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA.</Affiliations>
            <ArticleChemicalList>60 kDa protein, Listeria monocytogenes;Antigens, Bacterial;Bacterial Proteins;Epitopes;H-2 Antigens</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antigens, Bacterial(immunology; metabolism); Bacterial Proteins(immunology; metabolism); Cells, Cultured; Epitopes; H-2 Antigens(immunology); Listeria monocytogenes(immunology); Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; T-Lymphocytes, Cytotoxic(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>156</Volume>
                <Issue>4</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>p60 217-225</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KYGVSVQDI</LinearSequence>
                        <StartingPosition>217</StartingPosition>
                        <EndingPosition>225</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P21171.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10000309</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 6</LocationOfData>
                <EpitopeId>34446</EpitopeId>
                <ReferenceStartingPosition>217</ReferenceStartingPosition>
                <ReferenceEndingPosition>225</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcLigandElution>
                        <LocationOfData>Table 1 and figure 7</LocationOfData>
                        <MhcLigandElutionId>15164</MhcLigandElutionId>
                        <HostOrganism>
                            <OrganismId>10090</OrganismId>
                        </HostOrganism>
                        <InVivoProcess>
                            <InVivoProcessType>No immunization</InVivoProcessType>
                        </InVivoProcess>
                        <InVitroAdministration>
                            <ProcessType>Antigen administered in vitro</ProcessType>
                            <ProcessedAntigenReferenceName>L. monocytogenes</ProcessedAntigenReferenceName>
                            <ProcessedAntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000309</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </ProcessedAntigenObject>
                            <ProcessedAntigenEvidenceCode>Exact match to reference information</ProcessedAntigenEvidenceCode>
                        </InVitroAdministration>
                        <MhcLigand>
                            <MhcLigandReferenceName>p60 217-225</MhcLigandReferenceName>
                            <MhcLigandObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYGVSVQDI</LinearSequence>
                                        <StartingPosition>217</StartingPosition>
                                        <EndingPosition>225</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P21171.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10000309</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </MhcLigandObject>
                        </MhcLigand>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Inferred by motif or alleles present</MhcEvidenceCode>
                        </MhcAllele>
                        <AssayInformation>
                            <AssayTypeId>92</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Numbers of epitope molecules presented by infected cells were measured in the presence or absence of proteasome inhibitors (N-acetyl-Leu-Leu-norleucinal (LLnL) and benzyloxycarbonyl-Leu-Leu-phenylalaninal (Z-LLF)). Both  proteasome inhibitors (LLnL and Z-LLF) blocked presentation of the epitope in L. monocytogenes infected J774 cells in a dose dependent manner, more strongly than the inhibition of p60 449-457 presentation, and at concentrations that did not prevent p60 degradation.</AssayComments>
                        </AssayInformation>
                    </MhcLigandElution>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p60 449-457</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IYVGNGQMI</LinearSequence>
                        <StartingPosition>449</StartingPosition>
                        <EndingPosition>457</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P21171.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10000309</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 6</LocationOfData>
                <EpitopeId>29715</EpitopeId>
                <ReferenceStartingPosition>449</ReferenceStartingPosition>
                <ReferenceEndingPosition>457</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcLigandElution>
                        <LocationOfData>Table 1 and figure 7</LocationOfData>
                        <MhcLigandElutionId>15165</MhcLigandElutionId>
                        <HostOrganism>
                            <OrganismId>10090</OrganismId>
                        </HostOrganism>
                        <InVivoProcess>
                            <InVivoProcessType>No immunization</InVivoProcessType>
                        </InVivoProcess>
                        <InVitroAdministration>
                            <ProcessType>Antigen administered in vitro</ProcessType>
                            <ProcessedAntigenReferenceName>L. monocytogenes</ProcessedAntigenReferenceName>
                            <ProcessedAntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000309</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </ProcessedAntigenObject>
                            <ProcessedAntigenEvidenceCode>Exact match to reference information</ProcessedAntigenEvidenceCode>
                        </InVitroAdministration>
                        <MhcLigand>
                            <MhcLigandReferenceName>p60 449-457</MhcLigandReferenceName>
                            <MhcLigandObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IYVGNGQMI</LinearSequence>
                                        <StartingPosition>449</StartingPosition>
                                        <EndingPosition>457</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P21171.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10000309</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </MhcLigandObject>
                        </MhcLigand>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Inferred by motif or alleles present</MhcEvidenceCode>
                        </MhcAllele>
                        <AssayInformation>
                            <AssayTypeId>92</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Numbers of epitope molecules presented by infected cells were measured in the presence or absence of proteasome inhibitors (N-acetyl-Leu-Leu-norleucinal (LLnL) and benzyloxycarbonyl-Leu-Leu-phenylalaninal (Z-LLF)). Both proteasome inhibitors (LLnL and Z-LLF) blocked presentation of the epitope in L. monocytogenes infected J774 cells in a dose dependent manner, more weakly than the inhibition of p60 217-225 presentation, and at concentrations that coincided with the  prevention of p60 degradation.</AssayComments>
                        </AssayInformation>
                    </MhcLigandElution>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

